NCT06338397View on ClinicalTrials.gov

Social & Affective Cognition in Alzheimer's Disease & Associated Disorders

NANot yet recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

May 2, 2024

Primary Completion Date

May 2, 2027

Study Completion Date

May 2, 2027

Conditions
Alzheimer's DiseaseFrontotemporal Degeneration (Semantic & Behavioral Variants)
Interventions
OTHER

SCANN

Administering 11 tests of social \& affective cognition to each participant as well as 6 scales to their study-partner, in order to have a detailed profile of social \& affective cognitive abilities that we can correlate to an 3DMRI with resting state procedure.

All Listed Sponsors
collaborator

France Alzheimer

OTHER

lead

University Hospital, Lille

OTHER

NCT06338397 - Social & Affective Cognition in Alzheimer's Disease & Associated Disorders | Biotech Hunter | Biotech Hunter